A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors
Clinical trial NCT05716295 · TERMINATED
Trial details
- NCT number
- NCT05716295
- Sponsor
- Medikine, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-08
- Primary completion
- 2024-04-30
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.